Author:
Kim Namkwon,Do Jimin,Ju In Gyoung,Jeon Seung Ho,Lee Jong Kil,Oh Myung Sook
Funder
National Research Foundation of Korea
Korea Institute of Planning and Evaluation for Technology in Food, Agriculture and Forestry
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Neurology (clinical),Pharmacology
Reference40 articles.
1. Winblad, B., Amouyel, P., Andrieu, S., Ballard, C., Brayne, C., Brodaty, H., et al. Defeating Alzheimer’s disease and other dementias: a priority for European science and society. Lancet Neurol. 2016,15:455-532.
2. Donev, R., Kolev, M., Millet, B., Thome, J. Neuronal death in Alzheimer’s disease and therapeutic opportunities. J Cell Mol Med. 2009,13:4329-48.
3. Sevigny, J., Chiao, P., Bussiere, T., Weinreb, P. H., Williams, L., Maier, M., et al. Addendum: The antibody aducanumab reduces Abeta plaques in Alzheimer’s disease. Nature. 2017,546:564.
4. Bloom, G. S. Amyloid-beta and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol. 2014,71:505-8.
5. Casey, D. A., Antimisiaris, D., O’Brien, J. Drugs for Alzheimer’s disease: are they effective? P T. 2010,35:208-11.
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献